194 related articles for article (PubMed ID: 23994796)
1. Chemokine receptors as therapeutic targets.
Yoshie O
Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(4):189-96. PubMed ID: 23994796
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of chemokine receptor antagonists.
Miao M; De Clercq E; Li G
Expert Opin Drug Metab Toxicol; 2020 Jan; 16(1):11-30. PubMed ID: 31903790
[No Abstract] [Full Text] [Related]
3. Expression and function of chemokine receptors on human thymocytes: implications for infection by human immunodeficiency virus type 1.
Taylor JR; Kimbrell KC; Scoggins R; Delaney M; Wu L; Camerini D
J Virol; 2001 Sep; 75(18):8752-60. PubMed ID: 11507220
[TBL] [Abstract][Full Text] [Related]
4. The unique target specificity of a nonpeptide chemokine receptor antagonist: selective blockade of two Th1 chemokine receptors CCR5 and CXCR3.
Gao P; Zhou XY; Yashiro-Ohtani Y; Yang YF; Sugimoto N; Ono S; Nakanishi T; Obika S; Imanishi T; Egawa T; Nagasawa T; Fujiwara H; Hamaoka T
J Leukoc Biol; 2003 Feb; 73(2):273-80. PubMed ID: 12554804
[TBL] [Abstract][Full Text] [Related]
5. Expression of chemokines and chemokine receptors during human renal transplant rejection.
Segerer S; Cui Y; Eitner F; Goodpaster T; Hudkins KL; Mack M; Cartron JP; Colin Y; Schlondorff D; Alpers CE
Am J Kidney Dis; 2001 Mar; 37(3):518-31. PubMed ID: 11228176
[TBL] [Abstract][Full Text] [Related]
6. Multiple determinants are involved in HIV coreceptor use as demonstrated by CCR4/CCL22 interaction in peripheral blood mononuclear cells (PBMCs).
Agrawal L; Vanhorn-Ali Z; Alkhatib G
J Leukoc Biol; 2002 Nov; 72(5):1063-74. PubMed ID: 12429730
[TBL] [Abstract][Full Text] [Related]
7. Chemokine receptors as specific anti-inflammatory targets in peripheral nerves.
Ubogu EE
Endocr Metab Immune Disord Drug Targets; 2011 Jun; 11(2):141-53. PubMed ID: 21476965
[TBL] [Abstract][Full Text] [Related]
8. HIV co-receptors as targets for antiviral therapy.
Schols D
Curr Top Med Chem; 2004; 4(9):883-93. PubMed ID: 15134547
[TBL] [Abstract][Full Text] [Related]
9. New chemokine targets for asthma therapy.
Garcia G; Godot V; Humbert M
Curr Allergy Asthma Rep; 2005 Mar; 5(2):155-60. PubMed ID: 15683617
[TBL] [Abstract][Full Text] [Related]
10. Anti-chemokine small molecule drugs: a promising future?
Proudfoot AE; Power CA; Schwarz MK
Expert Opin Investig Drugs; 2010 Mar; 19(3):345-55. PubMed ID: 20113217
[TBL] [Abstract][Full Text] [Related]
11. Patterns of chemokines and chemokine receptors expression in different forms of human periodontal disease.
Garlet GP; Martins W; Ferreira BR; Milanezi CM; Silva JS
J Periodontal Res; 2003 Apr; 38(2):210-7. PubMed ID: 12608917
[TBL] [Abstract][Full Text] [Related]
12. An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5.
Andrews G; Jones C; Wreggett KA
Mol Pharmacol; 2008 Mar; 73(3):855-67. PubMed ID: 18042736
[TBL] [Abstract][Full Text] [Related]
13. Chemokines and chemokine receptors in renal transplantation--from bench to bedside.
Fischereder M
Acta Physiol Hung; 2007 Mar; 94(1-2):67-81. PubMed ID: 17444276
[TBL] [Abstract][Full Text] [Related]
14. [Chemokines and chemokine receptors].
Yoshie O
Nihon Rinsho; 2012 Nov; 70 Suppl 8():212-7. PubMed ID: 23513839
[No Abstract] [Full Text] [Related]
15. Small-molecule antagonists of CCR5 and CXCR4: a promising new class of anti-HIV-1 drugs.
Seibert C; Sakmar TP
Curr Pharm Des; 2004; 10(17):2041-62. PubMed ID: 15279544
[TBL] [Abstract][Full Text] [Related]
16. Targeting chemokine receptors for HIV: past, present and future.
Fricker SP
Future Med Chem; 2015; 7(17):2311-5. PubMed ID: 26627446
[No Abstract] [Full Text] [Related]
17. [Advances in the study of small molecule antagonists of chemokine receptors as anti-asthma agents].
Ji HJ; Hu JF; Chen NH
Yao Xue Xue Bao; 2011 Nov; 46(11):1286-90. PubMed ID: 22260017
[TBL] [Abstract][Full Text] [Related]
18. Designing decoys for chemokine-chemokine receptor interaction.
Rajarathnam K
Curr Pharm Des; 2002; 8(24):2159-69. PubMed ID: 12369860
[TBL] [Abstract][Full Text] [Related]
19. The chemokine system, and its CCR5 and CXCR4 receptors, as potential targets for personalized therapy in cancer.
Weitzenfeld P; Ben-Baruch A
Cancer Lett; 2014 Sep; 352(1):36-53. PubMed ID: 24141062
[TBL] [Abstract][Full Text] [Related]
20. A novel small-molecule compound targeting CCR5 and CXCR3 prevents acute and chronic allograft rejection.
Akashi S; Sho M; Kashizuka H; Hamada K; Ikeda N; Kuzumoto Y; Tsurui Y; Nomi T; Mizuno T; Kanehiro H; Hisanaga M; Ko S; Nakajima Y
Transplantation; 2005 Aug; 80(3):378-84. PubMed ID: 16082334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
